ESC 365 - What have we learned from SGLT-2 Inhibitors in Heart Failure?

Open Access

What have we learned from SGLT-2 Inhibitors in Heart Failure?

Session: What have we learned from SGLT-2 inhibitors in heart failure?

Topic: Other

Speaker: Professor R. Fontes Carvalho (Vila Nova de Gaia, PT)

Sponsored by Boehringer Ingelheim

Event: ESC Asia with APSC & AFC 2020

Congress Presentation

Add to my library

About the speaker

Professor Ricardo Fontes Carvalho

Hospital Center of Vila Nova de Gaia/Espinho, Vila Nova de Gaia (Portugal)

28 presentations

7 followers

3 more presentations in this session

Welcome/Opening - What have we learned from SGLT-2 inhibitors in heart failure?

Speaker: Professor S. Kang (Seoul, KR)

Q&A - What have we learned from SGLT-2 inhibitors in heart failure?

Speaker: Professor S. Kang (Seoul, KR) Professor R. Fontes Carvalho (Vila Nova de Gaia, PT)

Closing/Conclusion - What have we learned from SGLT-2 inhibitors in heart failure?

Speaker: Professor S. Kang (Seoul, KR)

Access the full session

What have we learned from SGLT-2 inhibitors in heart failure?

Speakers: Professor R. Fontes Carvalho, Professor S. Kang, Professor S. Kang, Professor R. Fontes Carvalho, Professor S. Kang

About the event

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources